{"retracted":false,"update":{"timestamp":1454284800000,"doi":"10.1016/j.clon.2015.11.009","type":"err"},"doi":"10.1016/j.clon.2015.02.008","journal":"Clinical Oncology","publisher":"Elsevier BV","title":"Corrigendum to “Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits” [Clin Oncol 27 (7) (2015) 420–426]"}
